NCT07200934

Brief Summary

This study aims to identify the effect of adding TENS to the Mediterranean diet on appetite and liver enzymes in Nonalcoholic fatty liver patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 23, 2025

Completed
7 days until next milestone

Study Start

First participant enrolled

September 30, 2025

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 1, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 14, 2026

Completed
Last Updated

October 1, 2025

Status Verified

September 1, 2025

Enrollment Period

3 months

First QC Date

September 23, 2025

Last Update Submit

September 23, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Visual analogue scale for appetite (VAS)

    This method is used to evaluate the appetite level of fatty liver patients before and after treatment procedures. This method usually consists of a set of questions assessing hunger, fullness/satisfaction, desire to eat and prospective food intake the question is presented with a 100 mm horizontal line scale.

    12 weeks

  • Levels of liver transaminases aspartate transaminase (AST)

    It will be measured pre and post-treatment for all participants in both groups.

    12 weeks

  • Levels of liver alanine transaminase (ALT)

    It will be measured pre and post-treatment for all participants in both groups.

    12 weeks

Secondary Outcomes (3)

  • Body mass index (BMI)

    12 weeks

  • Relative fat mass (RFM)

    12 weeks

  • Fatigue Severity Scale (FSS)

    12 weeks

Study Arms (2)

TENS + Mediterranean Diet

EXPERIMENTAL

This group will consist of 25 patients, who will receive TENS treatment at T6 dermatome for 30 minutes, 3 times per week for 12 weeks, in addition to following Mediterranean diet for 12 weeks.

Device: Transcutaneous electrical stimulation (TENS)Other: Mediterranean Diet

Mediterranean Diet

ACTIVE COMPARATOR

This group will consist of 25 patients, who will follow Mediterranean diet only for 12 weeks.

Other: Mediterranean Diet

Interventions

The negative/active pad surface electrode will be applied at the T6 dermatome on the abdomen (is located at the left upper quadrant of the abdomen, 2 cm below the ribcage at the left midclavicular line) for stimulation and the passive/positive electrode will be applied on the left T6 costovertebral junction to complete the circuit. * The specific parameters of TENS will be burst mode, 2.0 Hz frequency, and 300 micro-seconds width * The patients will receive 3 times 30 min session each week for a period of consecutive 12 weeks. * The intensity of TENS will be gradually increased from 0 mA till the subject felt a comfortable tingling sensation beneath the electrode without any muscle contraction and pain.

TENS + Mediterranean Diet

The recommended composition of Mediterranean diet regimen: is characterized by a high intake of plant foods, fruits, vegetables, breads and other cereals (traditionally minimally refined), potatoes, beans, nuts and seeds; minimally processed, fresh fruits as a typical dessert, with sweets containing sugars or honey a few times per week; .a high intake of olive oil (especially virgin and extra-virgin olive oil) as the main source of fat; a moderate intake of dairy products (mostly as cheese and yoghurt); zero to four eggs per week; low to moderate amounts of fish and poultry; low amounts of red meat. The diet plan included generally 50% carbohydrates (from vegetables, fruits, legumes, and whole grains), 35% fats (from healthy oils, nuts, seeds, and fish), and 15% protein (from legumes, fish, nuts, dairy, poultry, and eggs).

Mediterranean DietTENS + Mediterranean Diet

Eligibility Criteria

Age35 Years - 45 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • The age will range from 35-45 years old.
  • BMI (Body Mass Index 30-34.9 kg/m2.)
  • With fatty liver infiltration confirmed by abdominal ultrasound
  • Elevated of liver enzymes as a primary marker
  • All patients are psychologically stable.

You may not qualify if:

  • History of cardiovascular or respiratory disease.
  • If any known endocrine diseases e.g. Hypothyroidism (which elevates liver enzymes and effects on appetite)
  • Any acute or chronic illness causing elevated liver enzymes other than fatty liver e.g. Hepatitis b, Hepatitis c
  • Any neurological illness or impairment can effect on sensation
  • Patients associated with infections, mental or malignant conditions.
  • Patients who have undergone any gastric surgery e.g. Bariatric surgery
  • Taking dietary supplement for weight reduction.
  • Patients who participating in any other exercise program.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Internal Medicine Hospital Cairo University

Giza, Egypt

Location

MeSH Terms

Conditions

Non-alcoholic Fatty Liver Disease

Interventions

Transcutaneous Electric Nerve StimulationDiet, Mediterranean

Condition Hierarchy (Ancestors)

Fatty LiverLiver DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and AnalgesiaDiet, Plant-BasedDiet TherapyNutrition TherapyDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Nesreen Ghareeb El-Nahas, PhD

    Professor, Cairo university

    STUDY CHAIR
  • Salma Ibrahim AL Ghitany, PhD

    Lecturer, Cairo university

    STUDY DIRECTOR
  • Shawky Abdelhamid Fouad Abdel Gawad

    Professor, Cairo university

    STUDY DIRECTOR

Central Study Contacts

Doaa Anwar Mohamed Ali, B.Sc

CONTACT

Salma Ibrahim AL Ghitany, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 23, 2025

First Posted

October 1, 2025

Study Start

September 30, 2025

Primary Completion

December 30, 2025

Study Completion

January 14, 2026

Last Updated

October 1, 2025

Record last verified: 2025-09

Locations